Preferred Label : OPC-67683;
MeSH note : a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis
in vitro and in mice;
Is substance : O;
Origin ID : C516022;
UMLS CUI : C1873341;
Automatic exact mappings (from CISMeF team)
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3269474/fr/deltyba-delamanid
2021
false
false
false
France
evaluation of the transparency committee
delamanid
OPC-67683
nitroimidazoles
oxazoles
tuberculosis, pulmonary
delamanid
treatment outcome
insurance, health, reimbursement
administration, oral
antibiotics, antitubercular
tuberculosis, multidrug-resistant
adult
adolescent
child
---
https://ansm.sante.fr/tableau-marr/delamanide
2021
false
false
false
France
French
risk management
delamanid
administration, oral
delamanid
patient education handout
pregnancy
breast feeding
delamanid
long qt syndrome
pharmacovigilance note
drug resistance, bacterial
antibiotics, antitubercular
antibiotics, antitubercular
OPC-67683
OPC-67683
nitroimidazoles
oxazoles
nitroimidazoles
oxazoles
---
https://www.has-sante.fr/jcms/p_3120940/fr/deltyba
2019
false
false
false
France
administration, oral
insurance, health, reimbursement
treatment outcome
delamanid
delamanid
antibiotics, antitubercular
tuberculosis, multidrug-resistant
tuberculosis, pulmonary
adult
evaluation of the transparency committee
OPC-67683
nitroimidazoles
oxazoles
---
http://www.has-sante.fr/portail/jcms/c_2598638/fr/deltyba
http://www.has-sante.fr/portail/jcms/c_2598638/fr/deltyba-delamanide-antituberculeux
2016
false
France
French
treatment outcome
delamanid
delamanid
delamanid
OPC-67683
OPC-67683
antibiotics, antitubercular
antibiotics, antitubercular
orphan drug production
drug therapy, combination
tuberculosis, multidrug-resistant
tuberculosis, pulmonary
continuity of patient care
mycobacterium tuberculosis
adult
administration, oral
nitroimidazoles
nitroimidazoles
oxazoles
oxazoles
evaluation of the transparency committee
antibiotic therapy
guidelines for drug use
---
https://www.ema.europa.eu/medicines/human/EPAR/Deltyba
2014
false
United Kingdom
French
English
drug approval
europe
treatment outcome
delamanid
delamanid
delamanid
OPC-67683
OPC-67683
antibiotics, antitubercular
antibiotics, antitubercular
orphan drug production
drug therapy, combination
tuberculosis, multidrug-resistant
tuberculosis, pulmonary
continuity of patient care
drug monitoring
mycobacterium tuberculosis
adult
administration, oral
drug interactions
pregnancy
summary of product characteristics
package leaflet
drug evaluation
syndication feed
breast feeding
drug evaluation, preclinical
product surveillance, postmarketing
nitroimidazoles
nitroimidazoles
oxazoles
oxazoles
antibiotic therapy
---
